Comment from BUPRJ, IRHTP, RJMLC

Summary: The Boston University School of Law, representing three of its programs, submits a comment supporting the citizen petitions to safeguard access to mifepristone. They argue that the FDA should eliminate the Mifepristone Shared System Risk Evaluation and Mitigation Strategy (REMS) and expand telehealth access, asserting that current restrictions disproportionately burden marginalized communities, low-income individuals, and those in medically underserved areas.